Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...
Earnings call Divi’s Laboratories reported strong Q2 FY25 results with consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose 46.6% YoY to ₹510 crore. Growth was led ...
Reported Consolidated quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,604.00 crore in December 2025 up 12.29% ...
Trade Brains on MSN
Can Divi's Labs generate $1 billion from GLP-1 projects by FY32?
India, March 12 -- Broking Jefferies is still optimistic about Divi's Laboratories and has stated that the company is set to benefit from the growing importance of the global GLP-1 drug supply chain.
HYDERABAD, India--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active ...
Stock market today: Indian equity indices remained largely unchanged on Wednesday as financial stocks retraced from their near-record peaks, counterbalancing the positive sentiment surrounding a ...
Divi's Laboratories proposes ₹30 per share final dividend for FY25 Stock price reaches record ₹6,764, up 4.37 percent New long-term pharma supply deal triggers ₹650-750 crore investment Shares of ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of ...
Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...
Earnings call Divi's Laboratories reported Q3 FY26 revenue of ₹2,692 Cr, up 12.1% YoY, with profit before tax (ex-exceptional) rising 17.6% YoY to ₹854 Cr. Gross margin improved significantly due to ...
Reported Standalone quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,578.00 crore in December 2025 up 12.23% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results